These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8992134)

  • 1. [The therapeutic applications of octreotide].
    Carrera-Hueso FJ; Carrera-Hueso JA; Llorente I
    Med Clin (Barc); 1996 Apr; 106(13):505-16. PubMed ID: 8992134
    [No Abstract]   [Full Text] [Related]  

  • 2. Octreotide in pediatric patients.
    Heikenen JB; Pohl JF; Werlin SL; Bucuvalas JC
    J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):600-9. PubMed ID: 12454572
    [No Abstract]   [Full Text] [Related]  

  • 3. Octreotide.
    Lamberts SW; van der Lely AJ; de Herder WW; Hofland LJ
    N Engl J Med; 1996 Jan; 334(4):246-54. PubMed ID: 8532003
    [No Abstract]   [Full Text] [Related]  

  • 4. [Editor's commentary: Clinical use of somatostatin].
    Tulassay Z
    Orv Hetil; 2013 Sep; 154(39):1526. PubMed ID: 24058096
    [No Abstract]   [Full Text] [Related]  

  • 5. Octreotide (sandostatin, sandoz).
    Mac Connachie AM
    Intensive Crit Care Nurs; 1996 Apr; 12(2):120-1. PubMed ID: 8845623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to use octreotide for malignant bowel obstruction.
    Ripamonti C; Mercadante S
    J Support Oncol; 2004; 2(4):357-64. PubMed ID: 15357519
    [No Abstract]   [Full Text] [Related]  

  • 7. Octreotide in malignant intestinal obstruction.
    Pandha HS; Waxman J
    Anticancer Drugs; 1996 Jan; 7 Suppl 1():5-10. PubMed ID: 8822079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide treatment for chylothorax after congenital heart surgery.
    Tavli V; Yilmazer MM; Guven B; Mese T; Lafci B; Gurbuz A
    J Card Surg; 2009; 24(5):570-1. PubMed ID: 19740301
    [No Abstract]   [Full Text] [Related]  

  • 9. [A trial of the use of sandostatin in patients with chronic pancreatitis].
    Loginov AS; Sadokov VM; Vinokurova LV; Chernoiarova OD; Astaf'eva OV; Nilova TV
    Ter Arkh; 1995; 67(7):60-2. PubMed ID: 7482309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide.
    Murphy E; Prommer EE; Mihalyo M; Wilcock A
    J Pain Symptom Manage; 2010 Jul; 40(1):142-8. PubMed ID: 21634046
    [No Abstract]   [Full Text] [Related]  

  • 11. Octreotide.
    Stajich GV; Ashworth L
    Neonatal Netw; 2006; 25(5):365-9. PubMed ID: 16989134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide-induced bradycardia.
    Herrington AM; George KW; Moulds CC
    Pharmacotherapy; 1998; 18(2):413-6. PubMed ID: 9545165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of octreotide on gastric mucosal massive hemorrhage in patients with portal hypertensive gastropathy].
    Le Q; Zhang J; Xu Q; Gao H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):68. PubMed ID: 11856512
    [No Abstract]   [Full Text] [Related]  

  • 14. Established and potential therapeutic applications of octreotide in palliative care.
    Prommer EE
    Support Care Cancer; 2008 Oct; 16(10):1117-23. PubMed ID: 18256859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].
    Laczi F; Magony S; Julesz J
    Orv Hetil; 2002 May; 143(19 Suppl):1062-6. PubMed ID: 12063861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Octreotide (Famsynthesis): new possibilities in gastroenterology].
    Velichko MA; Vreshch VD
    Voen Med Zh; 2001 May; 322(5):44-5. PubMed ID: 11550331
    [No Abstract]   [Full Text] [Related]  

  • 17. Octreotide and hepatocellular carcinoma.
    Farinati F; Sergio A; Baldan A; Zucchetta P; Corleto VD
    Br J Cancer; 2007 Jun; 96(11):1778-9. PubMed ID: 17505506
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic octreotide therapy can induce pancreatic insufficiency: a common but under-recognized adverse effect.
    Saif MW; Larson H; Kaley K; Shaib W
    Expert Opin Drug Saf; 2010 Nov; 9(6):867-73. PubMed ID: 20662741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of treating malignant bowel obstruction.
    J Support Oncol; 2006 Feb; 4(2):83-4. PubMed ID: 16499129
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary intestinal lymphangiectasia in children: is octreotide an effective and safe option in the treatment?
    Sari S; Baris Z; Dalgic B
    J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):454-7. PubMed ID: 20512058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.